Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 14Prostatic Neoplasms 4Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Precancerous Conditions 2Peripheral Nervous System Diseases 2Lung Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Breast Carcinoma In Situ 2Weight Loss 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Polycystic Ovary Syndrome 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1

Interventions

fludarabine phosphate 3Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3Curcumin 3Whole-Body Irradiation 2Tacrolimus 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cyclosporine 2Busulfan 2Biopsy 2Antilymphocyte Serum 2pyroxamide 1piperine 1liposomal amphotericin B 1isatuximab 1ibrutinib 1ferrous sulfate 1ferric gluconate 1aldesleukin 1Urination 1Topotecan 1Tissue Banks 1Therapeutics 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Sucrose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Monoclonal Gammopathy of Undetermined Significance × Fatty Acids, Omega-3 × Clear all
NCT00899353 2013-12-12

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Marshall University

Phase 2 Terminated
16 enrolled 6 charts
LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡